MED18

MED18 is a head-module subunit of the Mediator complex that contributes both to transcription initiation and, at a subset of genes, to transcription termination (PMID:16964259, PMID:21921038). Within the head module it forms a Med8/Med18/Med20 subcomplex in which Med18 adopts a beta-barrel fold; proper trimer assembly requires the concurrent co-folding of all three subunits, and the submodule presents a conserved protein-interaction face whose mutation counteracts defects from Pol II truncation, linking it to initiation-complex formation through Med8-mediated TBP binding (PMID:16964259, PMID:19934057). The mammalian ortholog is a bona fide Mediator subunit with defined pairwise contacts to other Mediator subunits (PMID:12584197). Beyond initiation, yeast Srb5/Med18 is required for proper termination at a subset of genes (INO1, CHA1): its loss leaves TBP and TFIIB promoter recruitment intact but compromises recruitment of cleavage-polyadenylation factors to gene 3' ends, causing Pol II accumulation and readthrough (PMID:21921038). This termination role operates through gene looping, as Med18 physically interacts with the CF1 cleavage factor complex and this interaction, along with looped gene architecture, is abolished in looping-defective cells (PMID:23476016). In human cells, MED18 also acts as a transcriptional repressor at specific promoters through a CDK8-dependent mechanism that is independent of HDAC activity (PMID:24840924).

1. 2003 High

   Establishing that the mammalian Srb5 homolog is a genuine Mediator subunit was the prerequisite for studying its function in human transcription.

   Evidence tandem mass spectrometry of purified Med8-containing Mediator fractions with pairwise binding assays

   PMID:12584197

   Open questions at the time

   • Does not define the structural organization of the subunit within the head module
   • No functional consequence of the subunit assignment tested
2. 2006 High

   The crystal structure resolved how Med18 is organized within the head module and tied it mechanistically to initiation-complex formation.

   Evidence X-ray crystallography of the Med8/Med18/Med20 submodule, in vitro TBP-binding assay, and srb mutation epistasis

   PMID:16964259

   Open questions at the time

   • TBP binding is attributed to the Med8 N-terminus, not Med18 directly
   • Does not address roles outside initiation
3. 2009 High

   Reconstitution defined the assembly logic of the head submodule, showing Med8, Med18, and Med20 must co-fold to form a stable trimer.

   Evidence immunoprecipitation, far-UV circular dichroism, and fluorescence spectroscopy on recombinant renatured proteins

   PMID:19934057

   Open questions at the time

   • In vitro renaturation may not recapitulate in vivo assembly chaperones
   • Does not connect folding interdependence to a transcriptional output
4. 2009 Low

   A genetic screen linked Med18 function to the Pol II core enzyme via Rpb11, hinting at a Mediator–polymerase functional coupling.

   Evidence multicopy suppressor screen of the Rpb11 L111A mutation in yeast

   PMID:19928061

   Open questions at the time

   • Genetic suppression only; no biochemical evidence of a direct Med18–Rpb11 interaction
   • Single lab, not independently validated
5. 2011 Medium

   Med18 was assigned an unexpected role in transcription termination distinct from its initiation function, showing it is required for 3'-end processing factor recruitment at specific genes.

   Evidence ChIP and transcription run-on analysis in srb5-null yeast at INO1 and CHA1

   PMID:21921038

   Open questions at the time

   • Mechanism by which a head-module subunit influences 3'-end events left unexplained
   • Limited to a subset of genes
6. 2013 Medium

   Gene looping was identified as the mechanism connecting Med18 to termination, via a physical interaction with the CF1 cleavage factor complex.

   Evidence co-IP, ChIP, chromosome conformation capture, and the looping-defective sua7-1 mutant in yeast

   PMID:23476016

   Open questions at the time

   • Interaction specificity to CF1 versus CPF needs deeper structural definition
   • Does not establish whether human MED18 performs the same looping role
7. 2014 Medium

   Human MED18 was shown to act as a CDK8-dependent transcriptional repressor at specific promoters, distinguishing its mammalian role from the positive initiation function.

   Evidence siRNA knockdown, promoter ChIP, and HDAC inhibitor controls at RAM/FAM103A1 and DMT1/SLC11A2 in human cells

   PMID:24840924

   Open questions at the time

   • Direct molecular basis of CDK8-dependent repression unresolved
   • Generality beyond the tested target promoters unknown

• How Med18's initiation, termination/looping, and CDK8-dependent repression activities are integrated across organisms and gene classes remains unresolved.
• No structural model of Med18 engaging CF1 or CDK8
• Conservation of the looping/termination role in human cells untested
• Determinants of gene-selective repression versus activation unknown